Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
12
|
pubmed:dateCreated |
1990-6-25
|
pubmed:abstractText |
The lymphocyte subpopulations in tumor-draining lymph nodes of melanoma patients were determined using two-color flow cytometry. Data were analyzed according to: (a) the staging of the melanoma; (b) whether or not the nodes contained tumor; and (c) their distance from the primary tumor. Compared with Stage I patients (without metastasis), uninvolved nodes of stage II patients (with nodal metastases) had a significant decrease in helper/inducer (CD4+) T-cells (P less than 0.001), with a corresponding increase in cytotoxic/suppressor (CD8+) cells (P less than 0.001) and Leu 19+ natural killer (CD56+) cells (P less than 0.01). In some patients the presence of tumor within a node was associated with a large decrease in CD3+ total T-cells, whereas in others tumor involvement had little influence on lymphocyte phenotypes. When analyzed by distance from the primary tumor, nodes closest to tumor in Stage I patients contained a smaller percentage of CD19+ B-cells. In Stage II, tumor-free nodes nearest to tumor showed an increase in CD19+ cells, but statistical significance was not reached. CD56+ natural killer cells increased progressively in nodes near tumor and were more numerous in Stage II uninvolved nodes compared with Stage I nodes. Alterations in phenotypically defined lymph node lymphocytes occur in nodes regional to melanoma as the disease progresses, as growth of metastases occurs, and in tumor-free nodes nearest to tumor. These alterations may be essential to the establishment and progression of metastases.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0008-5472
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
50
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
3585-8
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:1692763-Adult,
pubmed-meshheading:1692763-Aged,
pubmed-meshheading:1692763-Antigens, CD4,
pubmed-meshheading:1692763-Antigens, CD56,
pubmed-meshheading:1692763-Antigens, CD8,
pubmed-meshheading:1692763-Antigens, Differentiation, T-Lymphocyte,
pubmed-meshheading:1692763-Axilla,
pubmed-meshheading:1692763-Flow Cytometry,
pubmed-meshheading:1692763-Humans,
pubmed-meshheading:1692763-Lymphatic Metastasis,
pubmed-meshheading:1692763-Lymphocytes,
pubmed-meshheading:1692763-Melanoma,
pubmed-meshheading:1692763-Middle Aged,
pubmed-meshheading:1692763-Neoplasm Staging,
pubmed-meshheading:1692763-Phenotype
|
pubmed:year |
1990
|
pubmed:articleTitle |
Lymphocyte subset alterations in nodes regional to human melanoma.
|
pubmed:affiliation |
Division of Surgical Oncology, University of California, Los Angeles 90024.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|